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Splenic red pulp macrophages (RPM) degrade se-
nescent erythrocytes and recycle heme-associated
iron. The transcription factor SPI-C is selectively ex-
pressed by RPM and is required for their develop-
ment, but the physiologic stimulus inducing Spic is
unknown. Here, we report that Spic also regulated
the development of F4/80+VCAM1+ bone marrow
macrophages (BMM) and that Spic expression in
BMM and RPM development was induced by
heme, ametabolite of erythrocyte degradation. Path-
ologic hemolysis induced loss of RPM and BMM due
to excess heme but induced Spic in monocytes to
generate new RPM and BMM. Spic expression
in monocytes was constitutively inhibited by the
transcriptional repressor BACH1. Heme induced pro-
teasome-dependent BACH1 degradation and rapid
Spic derepression. Furthermore, cysteine-proline
dipeptide motifs in BACH1 that mediate heme-
dependent degradation were necessary for Spic in-
duction by heme. These findings are the first example
of metabolite-driven differentiation of a tissue-resi-
dent macrophage subset and provide new insights
into iron homeostasis.INTRODUCTION
Macrophage function extends beyond immunity to include roles
in embryonic development, wound repair, and local tissue
homeostasis (Pollard, 2009; Murray and Wynn, 2011). Macro-
phages in various tissues have distinct tissue-specific homeo-static roles, such as osteoclasts that regulate bone morphogen-
esis, alveolar macrophages that regulate pulmonary surfactant
turnover, and splenic red pulp macrophages (RPM) that regulate
erythrocyte degradation and iron recycling (Pollard, 2009; Gor-
don and Taylor, 2005; Taylor et al., 2005; Murray and Wynn,
2011; Marks and Lane, 1976; Cecchini et al., 1994; Shibata
et al., 2001; Dranoff et al., 1994; Kohyama et al., 2009). These tis-
sue-resident macrophages are thought to be maintained by the
differentiation of circulating monocytes and local proliferation
(Landsman and Jung, 2007; Jenkins et al., 2011; Hume, 2008).
Recently, a subset of tissue-resident macrophages have been
shown to arise from cells in the primitive ectoderm of the yolk
sac without a monocytic intermediate (Schulz et al., 2012a).
However, factors controlling the relative contribution of yolk-
sac-derived and monocyte-derived macrophages are unknown.
RPM, and to some extent bone marrow macrophages (BMM)
and liver macrophages, phagocytose senescent or damaged
erythrocytes to degrade heme and release the heme-associated
iron (Ganz, 2012; Beaumont and Delaby, 2009). Iron is an essen-
tial element required for many critical biological processes
(Pantopoulos et al., 2012). The majority of iron in the body is con-
tained within the heme moiety of hemoglobin inside erythro-
cytes, and each day about 3.6 3 1011 erythrocytes are recycled
by the macrophage-dependent pathway, supplying the vast
majority of the daily iron requirement (Andrews and Schmidt,
2007; Ganz, 2012; Pantopoulos et al., 2012; Bratosin et al.,
1998). Given the proficiency of RPM and BMM in erythrophago-
cytosis, these cells experience significant increases in intra-
cellular heme following erythrocyte damage in pathological
conditions such as autoimmune hemolytic anemia, drug- or
toxin-induced hemolysis, and sickle cell disease (Guillaud
et al., 2012). However, very high levels of intracellular heme are
toxic to these cells as demonstrated by the elimination of RPM
and BMM upon inactivation of the heme-degrading enzyme
heme oxygenase 1 (HO1) (Kovtunovych et al., 2010). Indeed,Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc. 1223
excess intracellular heme is toxic to macrophages even with
intact Ho1 (Cambos and Scorza, 2011). Therefore, conditions
leading to increased heme levels may require ‘‘replenishment’’
of the RPM and BMM population to maintain iron homeostasis.
We have previously reported the requirement of the transcrip-
tion factor SPI-C for the development of RPM (Kohyama et al.,
2009). To examine the signals controlling Spic induction and
RPM development in vivo, we targeted enhanced green fluores-
cent protein (EGFP) for expression under the control of the native
Spic locus. Our analysis demonstrated that it is the heme moiety
derived from senescent or damaged erythrocytes that is the
physiologic trigger for inducing Spic. This induction appeared
to take place in a subset of monocytes and proceeds by the
heme-mediated degradation of BACH1 protein, a transcriptional
repressor that inhibited Spic under normal conditions. We found
that Spic also regulated BMM that phenotypically resembled
RPM, and that the heme-BACH1-Spic circuit induced compen-
satory development of RPM and BMM during pathological
hemolysis. These findings uncover a novel metabolite-driven
pathway regulating tissue-specific macrophage development
and provide insights into iron homeostasis.
RESULTS
Spic Is Required for the Development of F4/80hi
Macrophages in the Spleen and Bone Marrow
Spic encodes amember of the Spi subfamily of ETS transcription
factors and is required for the development of RPM (Bemark
et al., 1999; Carlsson et al., 2002; Kohyama et al., 2009). To
examine Spic regulation, we generated a Spicigfp allele by insert-
ing an internal ribosomal entry site (IRES) and EGFP expression
cassette immediately downstream of the Spic gene stop codon
(Figures S1A and S1B available). This strategy does not disrupt
the endogenous Spic coding sequence and allows tracking of
Spic expression in the context of normal RPM development.
Spicigfp/+ andSpicigfp/igfpmicewere born atMendelian frequency
and developed normally and had normal development of RPM
(Figure S1C). Spic-EGFP+ splenocytes expressed significantly
more Spic transcripts compared to Spic-EGFP splenocytes in
Spicigfp/+ mice, indicating that the EGFP levels reflect endoge-
nous Spic transcription (Figure S1D).
As expected, EGFP levels were high in RPM (Figures 1A and
1B). We also observed high levels of EGFP in F4/80hi cells in
the bonemarrow (BM) (Figures 1A and 1B) and in a small fraction
of F4/80hi cells in the liver, but not in other locations (Figure S2A).
Spic-EGFPhi cells in the BM expressed low levels of the myeloid
marker CD11b but were neither neutrophils (Ly6Ghi) nor mono-
cytes (Ly6Chi) (Figure 1C). However, these Spic-EGFPhi BM cells
expressed high levels of macrophage-associated markers
including F4/80, VCAM1, CD68, and CD169, supporting their
identity as BMM (Figure 1C). Furthermore, Spic-EGFPhi BMM
displayed a striking similarity to RPM (Kohyama et al., 2009;
Hemmi et al., 2009), with both cells being CD11blo MHCIIint
VCAM1hi TREML4hi (Figures S2B–S2E). BMM and RPM were
negative for the dendritic cell-specific marker Zbtb46 (Satpathy
et al., 2012) and dendritic cells did not express Spic-EGFP
(Figure S2F). These results demonstrated that Spic is expressed
at high levels in both BMM and RPM, suggesting a common1224 Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc.developmental origin for these macrophage subsets. Indeed,
Spic/ mice were found to be deficient in F4/80hi VCAM1hi
BMM in addition to the previously reported loss of RPM
(Figure 1D). Macrophages in other locations surveyed were pre-
sent in normal numbers (Figure S2G).
Spic-EGFPhi BMM were F4/80hiVCAM1hiCD11bloCD169+
CD68+ (Figures 1C), which is similar to the reported surface
marker profile of the previously described CD169+ BMM
(Chow et al., 2011; Chow et al., 2013). CD169 expression was
significantly decreased in Spic/ BM, indicating loss of these
macrophages (Figure 1E). CD169+ BMM have been suggested
to support normal erythropoiesis in the BM (Chow et al., 2013).
Proerythroblast frequencies were reduced in the BM of Spic/
mice, which is consistent with the reported phenotype (Chow
et al., 2013) upon ablating CD169+ BMM (Figure 1F). Further-
more, hemoglobin recovery from hemolytic anemia appeared
impaired, albeit not statistically significantly, in Spic/ mice
(Figure S2H). Taken together, these results demonstrate the
role of Spic in regulating the development of F4/80hiVCAM1hi
CD169+ BMM.
Heme Induces Spic Expression in Macrophages
Generated In Vitro
We next considered factors that may induce Spic expression to
promote RPM and BMM development. Several potential RPM-
specific transcription factors failed to induce Spic-EGFP in
macrophages generated in vitro by culturingSpicigfp/igfpBMcells
in the presence of GM-CSF (BM-derived macrophages, BMDM).
Retroviral expression of Spic in BMDM did not induce Spic-
EGFP, arguing against autoactivation, and neither did Tcfec,
which encodes another RPM-associated transcription factor
(Figure S3A). Agonist-mediated activation of the nuclear recep-
tors NR1D1, PPARg, LXRa, and RXRa (Heng and Painter,
2008), which are each highly expressed in RPM, also failed to
induce Spic-EGFP (Figures S3B–S3D).
Since RPM and BMM have characteristically high levels of
intracellular heme, we next asked whether heme itself might
induce Spic. Indeed, heme (Hemin, Sigma-Aldrich) selectively
induced Spic-EGFP in F4/80+ macrophages and Ly6C+
monocytes, but not in Ly6G+ neutrophils, in BM cultures (Figures
2A, 2B, and S4A). Heme-induced Spic expression was con-
firmed by reverse transcription PCR and was dose-dependent
(Figure 2C).
The enzyme HO1 converts heme to biliverdin, releasing the
heme-associated iron, while the enzyme biliverdin reductase
(BLVR) converts biliverdin to bilirubin (Beaumont and Delaby,
2009). Thus, heme-induced Spic expression could be mediated
by heme itself or by one of these hememetabolites. Bilirubin and
biliverdin failed to induce Spic-EGFP in Spicigfp/igfp BMDM
(Figure 2D). Furthermore, iron chelation by deferoxamine or
HO1 inhibition by chromium mesoporphyrin (Crmp) (Schulz
et al., 2012b) failed to inhibit heme-mediated Spic-EGFP
induction (Figures S4B and S4C). These results argue against
a role for heme metabolites in Spic induction. We further
confirmed this interpretation by genetic analysis. Ho1/ mice
were obtained (Poss and Tonegawa, 1997a) to generate
Ho1/ Spicigfp/igfp mice. Heme induced Spic-EGFP expression
in Ho1/ Spicigfp/igfp BMDM (Figure 2E). Notably, BMDM were
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Figure 1. Spic Is Required for the Development of RPM and BMM
(A) Flow cytometry with the indicated markers on splenocytes and BM of the indicated genotypes.
(B) Fixed and frozen BM and spleen sections of the indicated genotypes were stained with the indicated antibodies and DAPI (for nuclei). Right: higher
magnification images of indicated regions (white box).
(C) Single-color histograms for the indicated markers on Spic-EGFPhi (red) and Spic-EGFP (blue) gated Spicigfp/igfp BM cells. Ly6G and Ly6C expression within
the Spic-EGFP gate represent cells additionally gated for CD11b expression.
(D) Flow cytometry with the indicated markers on splenocytes and BM of the indicated genotypes.
(E) Single-color histograms for CD169 expression in MHC-II+ BM cells of the indicated genotypes.
(F) Flow cytometry plots showing CD71 and Ter119 expression in CD45 BM cells of the indicated genotypes. Right: cumulative data from five mice of each
genotype (bar, mean + SD). *p < 0.05 (unpaired t test). Numbers in flow cytometry plots represent percentage of cells within the indicated gates. All data in this
figure are representative ofR3 mice.
See also Figures S1 and S2.increasingly sensitive to heme-mediated Spic induction with loss
of each allele of Ho1 (Figure 2E). These results further demon-
strate a direct role for heme in Spic induction.
Heme Induces Spic Expression in a Subset of Myeloid
Cells In Vivo
Ho1/ mice have been previously reported to lack RPM and
BMM (Kovtunovych et al., 2010). We noticed that the lack of
RPM and BMM in Ho1/Spicigfp/igfp was associated with a sig-nificant increase in cells expressing low levels of Spic-EGFP and
the myeloid lineage marker CD11b (CD11bhi Spic-EGFPlo cells)
in the spleen and BM, but not in other locations (Figures 3A
and S5A). HO1 inhibition by Crmp also increased the number
of CD11bhi Spic-EGFPlo cells while reducing RPM numbers
in vivo (Figure 3B). Additionally, induction of intravascular hemo-
lysis by phenylhydrazine (PDZ) (Itano et al., 1975; Chow et al.,
2013) recapitulated this phenomenon (Figures 3C and S5B).
Notably, within the spleen these CD11bhi Spic-EGFPlo cellsCell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc. 1225
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Figure 2. Heme Induces Spic Expression in
Macrophages Generated In Vitro
(A and B) BMDM of the indicated genotypes were
treated with heme or vehicle after 6–7 days in
culture. Adherent cells were harvested 2 days later
and stained with the indicated markers as shown
in the flow cytometry plots.
(C) BMDM were treated with vehicle or increasing
concentrations of heme after 6 days in culture.
Adherent cells were harvested 2 days later and
RNA extracted. Top: Expression of Spic (y axis,
log10) in response to vehicle or increasing levels of
heme (x axis) measured by real-time quantitative
PCR (bars: mean + SD). Results represent two
biological replicates with three technical replicates
for each sample. Spic expression was normalized
to Hprt and levels are relative to the expression in
vehicle-treated macrophages. Bottom: Repre-
sentative gel for RT-PCR products generated with
the indicated primers.
(D) BMDMof the indicated genotypes were treated
with heme (10 mM), biliverdin (BV, 50 mM), or bili-
rubin (BR, 50 mM) at the onset of culture. Cells were
harvested after 8 days in culture. Shown are
single-color histograms for EGFP expression in
cells gated for F4/80 expression. Numbers in the
flow cytometry plots represent percentage of cells
within the indicated gate. All data are representa-
tive of three or more experiments with at least two
replicates per group.
(E) BMDM of the indicated genotypes were treated
with heme or vehicle after 5 days in culture and
harvested 5 days later. Shown are the percentages
of 7AAD (live) cells expressing EGFP (bars: mean
with range, n = 2). *p < 0.05 (unpaired t test).
See also Figures S3 and S4.were located in the red pulp area, similar to RPM (Figure 3D).
These findings suggest a role of heme in the generation of
CD11bhi Spic-EGFPlo cells in vivo.
Loss of RPM in Ho1/ mice is thought to result from heme-
induced toxicity (Kovtunovych et al., 2010; Poss and Tonegawa,
1997b). Consistent with this, higher levels of heme induced the
loss of Ho1/Spicigfp/igfp BMDM (Figure 3E). Cell death was
induced within 24 hr of exposure to high levels of heme in
Ho1/ BMDM, demonstrating the increased sensitivity of
Ho1/ macrophages to heme-induced toxicity (Figure 3F).
Phagocytosis of senescent erythrocytes is the major source of
heme in RPM and mouse erythrocytes have a lifespan of about
40 days (Van Putten, 1958). Notably, while RPM and BMM
were absent in older (R2 months) Ho1/ Spicigfp/igfp mice,
they were present in younger (4–5 weeks) mice, further support-
ing that the loss of RPM in Ho1/ mice is secondary to heme-
induced toxicity (Figure S5C).
Since heme induced loss of RPM while expanding CD11bhi
Spic-EGFPlo cells, Spic expression in CD11bhi Spic-EGFPlo
cells may be directly induced by heme or, alternatively, may
be secondary to the loss of RPM. To distinguish between these
hypotheses, we treated Ho1/ Spicigfp/igfp mice with intraperi-
toneal (IP) heme. We reasoned that the IP heme would redis-
tribute throughout the body, leading to less drastic increases
in heme levels within RPM and BMM compared to PHDZ or1226 Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc.Crmp treatment, thereby mitigating cell death. IP heme robustly
induced CD11bhi Spic-EGFPlo cells in the spleen and BM
without significantly reducing the numbers of RPM or BMM
(Figures 3G and S5B, bottom). Furthermore, CD11bhi Spic-EGF-
Plo cells induced by HO1 deficiency, PDZ treatment, and heme
treatment shared similar surface marker profiles, including high
levels of TREML4 (Figure S5D). These results demonstrate a
direct role for heme in the generation of CD11bhi Spic-EGFPlo
cells in vivo.
Heme-Induced CD11bhi Spic-EGFPlo Cells Are Derived
from Monocytes
Heme-induced CD11bhi Spic-EGFPlo cells were Ly6GLy6C+/,
similar to monocytes (Figure 4A), and F4/80+TREML4hi similar to
RPM (Figure 4B), suggesting that CD11bhi Spic-EGFPlo cells
may represent a precursor of RPM (pre-RPM) intermediate be-
tween monocytes and RPM. Consistent with this, monocytes
(CD11bhiLy6C+Ly6GF4/80 Spic-EGFP), but not neutrophils
(CD11bhiLy6CLy6G+F4/80 Spic-EGFP) generated F4/80+
Spic-EGFP+ cells in the presence of heme in vitro (Figure 4C).
Conceivably, the loss of RPM (F4/80hiCD11blo) and the con-
current appearance of pre-RPM (F4/80+ CD11bhi) may reflect
decreased F4/80 and increased CD11b on RPM. While this is
unlikely because pre-RPM were induced without the loss of
RPM upon IP heme treatment, we ruled out this possibility using
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Figure 3. Heme Induces Spic Expression in Myeloid Cells In Vivo
(A) Splenocytes of the indicated genotypes were stained for the indicated markers as shown in the flow cytometry plots.
(B) WT and Spicigfp/igfp mice were treated intraperitoneally with 100 ml of PBS or Crmp (5 mM/kg in PBS) on 3 consecutive days. On day 4, splenocytes were
harvested and stained for the indicated markers as shown in the flow cytometry plots.
(C) WT and Spicigfp/igfp mice were treated intraperitoneally with 200 ml PBS or PDZ (2 mg in PBS) three times 48 hr apart and sacrificed 24 hr. after the final
treatment. Splenocytes were harvested and stained for the indicated markers as shown in the flow cytometry plots.
(D) Fixed and frozen sections of spleen of the indicated genotypes were stained with the indicated antibodies and DAPI. Bottom: higher magnification of the
indicated regions (white box).
(E) BMDMof the indicated genotypes were treated with vehicle or increasing concentrations of heme after 7 days in culture. Cells were harvested 2 days later and
stained for the indicated markers as shown in the flow cytometry plots.
(F) BMDM of the indicated genotypes were treated with vehicle or high concentration of heme after 5 days in culture. Cells were harvested 24 hr later,
stained for F4/80, and subsequently stained with annexin V and 7AAD. Shown are the flow cytometry plots with indicated markers on cells gated for F4/80
expression.
(legend continued on next page)
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an independent approach. BM chimeras were generated with
congenically marked donor cells. Consistent with previous
reports (Hashimoto et al., 2013), we observed significant persis-
tent host contribution to the RPM pool after BM transplantation
(Figure 4D). However, all pre-RPM (CD11bhi F4/80+) at the
steady state and upon induction by Crmp were exclusively of
donor origin (Figure 4D). This demonstrated that heme-induced
pre-RPM are not a result of an acute loss of F4/80 and induction
of CD11b on RPM, but rather are derived de novo from adult
hematopoietic stem cells.
We next asked whether, and under what conditions, mono-
cytes give rise to pre-RPM and RPM in vivo. Donor monocytes,
like unfractionated BM cells, generated pre-RPM and RPM-like
cells in the presence of hemolysis in the recipient host (Figures
4E and S6A). Donor monocytes were recovered from the recip-
ient spleen with or without hemolysis, demonstrating an equiva-
lent ingress of the transferredmonocytes (Figure S6A). However,
maturation of the transferred monocytes into pre-RPM (CD11bhi
F4/80+) and RPM (F4/80hiVCAM1hiCD11blo) required PDZ-
induced hemolysis and erythrocyte damage (Figure S6B). These
results demonstrate the role of heme in generating pre-RPM and
RPM from monocytes.
Heme-Induced CD11bhi Spic-EGFPlo Cells Give Rise
to RPM
To establish a developmental continuum between monocytes
(CD11bhiLy6C+ Spic-EGFP), pre-RPM (CD11bhiLy6C+ Spic-
EGFP+), and RPM (F4/80hiCD11blo Spic-EGFPhi), we compared
their transcriptional profile by gene expression microarray.
RPM-associated genes were expressed by pre-RPM at levels
intermediate between monocytes and RPM (Figure 4F). Indeed,
of all genes that differ in expression by more than 20-fold
between monocytes and RPM, 94% were expressed at
intermediate levels in pre-RPM (Figure S7A). Furthermore,
both Spic-EGFP monocytes and Spic-EGFP+ pre-RPM from
Spicigfp/igfp donors generated RPM-like cells when transferred
into Spic/ recipients in the presence of hemolysis, further sup-
porting a monocyte-pre-RPM-RPM developmental continuum
(Figure 4G).
Although PDZ treatment rapidly reduced the number of
F4/80hiCD11blo RPM while expanding F4/80loCD11bhi pre-
RPM, RPM and pre-RPM populations eventually returned to
their pretreatment frequencies, suggesting that heme-induced
monocyte-derived pre-RPM differentiate into RPM (Figure S7B).
To examine this phenomenon further, we generated congeni-
cally marked BM chimeras. In the absence of hemolysis, a
substantial fraction of RPM were of host origin, consistent
with their radio resistant property. Remarkably, hemolysis
induced a complete ‘‘takeover’’ of the RPM pool by donor-
derived cells (Figure 4H). Collectively, these results strongly
suggest that heme-induced pre-RPM generate RPM in the
spleen.(G) WT and Spicigfp/igfpmice were treated intraperitoneally with 200 ml of PBS or he
day 4 and stained for indicated markers as shown in the flow cytometry plots.
indicated gate. Red boxes represent RPM and blue boxes pre-RPM. All data in thi
samples per group.
See also Figure S5.
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To identify the molecular basis for heme-induced Spic expres-
sion, we used gene expression microarrays to compare BMDM
transcriptional profiles at various times after treatment with
heme (Figures 5A and 5B). Heme induced the expression of
Ho1 and Blvrb as well as Slc40a1, which encodes the mamma-
lian iron exporter (Figure 5A), in agreement with previous reports
(Delaby et al., 2008). In addition, Spic was induced as expected,
as was Treml4, which can be used as a marker for RPM
(Figure 5A). Spic was one of the most highly induced genes,
and was the only transcription factor the expression of which
was substantially altered (R4-fold) by heme. This suggests that
Spic expression may be induced by a heme-regulated posttran-
scriptional mechanism. Notably, some heme-induced genes
such as Ho1, Gclm, Me1, and Slc7a11 were targets of the
transcriptional repressor BTB and CNC homology 1 (BACH1)
(Figures 5A and 5B) (Warnatz et al., 2011). BACH1 and the related
factor BACH2 contain a BTB protein-protein interaction motif
that mediates transcriptional repression and a basic leucine
zipper (bZIP) domain thatmediates heterodimerizationwith other
bZIP transcription factors (Oyake et al., 1996). While BACH1
target genes were induced following heme treatment, Bach1
expression was unchanged (Figure 5B). Compared to Bach1,
Bach2 expression in BMM and RPM was very low (Figure 5B).
Heme is known to inhibit BACH1 repressive activity (Ogawa
et al., 2001), and heme-mediated induction of Spic-EGFP+
BMDM was significantly reduced with Bach1 overexpression,
suggesting that BACH1 may inhibit Spic expression (Figure 5C).
Next, we examined Bach1/ BMDM. While Bach1+/+ BMDM
expressed Spic only after heme treatment, Bach1/ BMDM
showed constitutive expression of Spic (Figure 5D). These
results demonstrate that BACH1 is a transcriptional repressor
of Spic that is inhibited by heme.
Heme-Mediated Degradation of BACH1 Induces Spic
Expression
Bach1 transcription was not altered by heme, suggesting post-
transcriptional regulation of its activity by heme. The microRNA
miR-155 has been shown to target Bach1 (Yin et al., 2008).
Therefore, we next asked if heme-mediated Spic induction
occurs via miR-155. RPM frequencies at steady state and RPM
recovery after hemolysis were normal inMir155/mice (Figures
6A and 6B). Importantly, heme induced robust Spic expression
in Mir155/ BMDM (Figure 6C). These results rule out a
significant role ofmiR-155 in heme-mediated Spic induction.
Heme has been suggested to induce polyubiquitination and
proteasome-dependent degradation of BACH1 (Zenke-Kawa-
saki et al., 2007; Tan et al., 2013). Consistent with this, we
observed reductions in BACH1 protein levels with increasing
heme in BMDM (Figure 6D). Notably, the disappearance of
BACH1protein coincidedwith the appearance of a highermolec-
ular weight band on western blot, suggesting posttranslationalme (0.5 mg in PBS) on three consecutive days. Splenocytes were harvested on
Numbers in the flow cytometry plots represent percentage of cells within the
s figure are representative of two or more experiments with at least twomice or
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Figure 4. Spic+ Myeloid Cells Are Inter-
mediates between Spic Monocytes and
Spichi RPM
(A and B) Splenocytes from Spicigfp/igfp and
Ho1/Spicigfp/igfp were stained for the indicated
markers. (A) Flow cytometry plots with the indi-
cated markers in CD11bhi EGFP (left) and
CD11bhi EGFP+ (right) gated cells from Ho1/
Spicigfp/igfp splenocytes. (B) Single-color histo-
grams for indicated markers in CD11bhiEGFP
and CD11bhiEGFP+ cells from Ho1/Spicigfp/igfp
splenocytes and CD11bloEGFPhi cells (RPM) from
Spicigfp/igfp splenocytes.
(C, left) 7AAD EGFP splenocytes pooled from
six Spicigfp/igfp mice were selected for CD11b
expression while gating out CD11chi F4/80hi cells.
Within these cells, monocytes (M) were sorted as
Ly6GLy6C+ and neutrophils (N) as Ly6G+Ly6C
cells. (C, right) Sorted monocytes and neutrophils
were cultured with 5 ng/ml GM-CSF with or
without heme (40 mM), harvested 3 days later, and
stained for markers as shown in the flow cytometry
plots.
(D) BM from CD45.2+ C57BL/6 donors were
transferred into lethally irradiated CD45.1+
C57BL/6 recipients and splenocytes harvested
after 8 weeks. Shown are the flow cytometry
plots indicating donor- and host-derived F4/80hi
CD11blo RPM (left) and F4/80+CD11bhi pre-RPM
(middle). The plot on the right shows the same for
pre-RPM induced by Crmp (5 mM/kg in150 ml PBS,
twice 24 hr apart) in the BM chimeras.
(E) Monocytes were purified from 129SvEv
Spicigfp/igfp splenocytes by depleting Ly6G+ gran-
ulocytes and enriching for CD11b+ cells using
MACS microbeads. 129SvEv Spic+/+ recipient
micewere irradiated oncewith 550 rad followed by
single treatment with 200 ml of intraperitoneal PBS
or PDZ (2 mg in PBS). About 2 3 106 monocytes
were injected (IV) into recipient mice 24 hr later.
Some recipient mice were injected with about 43
106 unfractionated 129SvEv Spicigfp/igfp BM cells
(instead of monocytes). Four days after the cell
transfers, recipient splenocytes were stained for
markers as shown in the flow cytometry plots. The
two-color flow cytometry plot at the bottom dis-
plays the overlapping pattern of F4/80 and CD11b
expression between BM and monocyte-derived
Spic-EGFP+ cells in the host spleen.
(F) Monocytes (CD11bhiLy6C+ Spic-EGFP), pre-
RPM (CD11bhiLy6C+ SpIic-EGFP+), and RPM
(F4/80hiCD11blo SpiIc-EGFPhi) were sorted from
Spicigfp/+mice. RNAwas extracted from the sorted
cells and gene expression analysis carried out using the Affymetrix expression platform. Shown is a heat map representing expression levels for selected
RPM-associated genes.
(G) 129SvEv Spicigfp/igfp mice were treated with 200 ml PDZ (2 mg in PBS). Splenocytes were harvested 48 hr later and enriched for CD11b+ cells using MACS
microbeads. Ter119Ly6GF4/80CD3B220CD11b+ cells from this fraction were sorted into Spic-EGFP+ and Spic-EGFP cells (left). About 2 3 106 Spic-
EGFP and 13 106 Spic-EGFP+ cells were injected (IV) into 129SvEv Spic/ recipients. Splenocytes from the recipients were harvested 4 days later. The two-
color flow cytometry plot on right displays the overlapping pattern of TREML4 and VCAM1 expression between Spic-EGFP+ and Spic-EGFP donor-derived
cells.
(H) Lethally irradiated CD45.1+ C57BL/6 mice were transplanted with CD45.2+ C57BL/6 BM cells and treated with two doses (48 hr apart) of 200 ml of PBS or PDZ
(2 mg in PBS) 5 weeks after radiation. Four weeks after treatment, splenocytes from the recipients were stained for the indicated markers as shown in the flow
cytometry plots. Numbers in the flow cytometry plots represent percentage of cells within the indicated gate. The data are representative of two or more ex-
periments with at least two mice per group.
See also Figures S6 and S7.
Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc. 1229
A B
C D
Figure 5. BACH1 Is a Repressor of Spic
Expression
(A and B) Spicigfp/igfp BMDM were treated with
heme (80 mM) or vehicle after 6 days in culture and
harvested 24 hr. after treatment. RNA was ex-
tracted and gene expression analysis performed
using the Affymetrix microarray platform. Shown
are expression levels (y axis) of selected genes in
vehicle (gray bars) and heme (black bars) treated
cells.
(C) Spicigfp/igfp BMDM were infected with retrovi-
ruses expressing mouse Bach1 and human Cd4
(Bach1-RV) or expressing only the human Cd4
(Empty-RV). Four days after infection, the cells
were treated with heme (40 mM) or vehicle. Cells
were harvested 4 days later and stained for the
indicated markers as shown in the flow cytometry
plots. Numbers in the flow cytometry plots repre-
sent percentage of cells within the indicated gate.
Data are representative of two or more experi-
ments with at least twomice or samples per group.
(D) Bach1/ BMDM were treated with heme
(40 mM) or vehicle after 6 days in culture. RNA
was extracted 48 hr. later and quantitative real-
time PCR performed for Spic transcripts. Shown is
the expression value (y axis, log10) relative to
vehicle treated WT cells and normalized to Hprt
expression (bars, mean + SD). Results represent
two distinct biological samples with three tech-
nical replicates for each biological sample.modifications, most likely polyubiquitination (Figure 6D). Further-
more, heme-mediated induction of Spic-EGFP+ BMDM was
blocked by the proteasome inhibitor MG132, supporting a
role for ubiquitination and proteasome-based degradation of
BACH1 in Spic induction by heme (Figure 6E).
BACH1 contains six heme-interacting cysteine-proline (CP)
dipeptide motifs (Figure 6F, top) (Ogawa et al., 2001). The four
carboxy-terminal CP motifs are thought to be particularly impor-
tant for heme-BACH1 interaction (Zenke-Kawasaki et al., 2007)
and thus we mutated these four CP motifs to alanine-proline
(AP) in order to disrupt heme binding (Figure 6F, top). As
expected, the mutant BACH1 protein was resistant to heme-
mediated degradation (Figure 6F, bottom). Notably, while over-
expression of wild-type (WT) BACH1 protein reduced the
expression of Spic-EGFP, mutant BACH1 completely blocked
heme-induced Spic-EGFP expression in BMDM (Figure 6G).
These results demonstrate the requirement for heme-BACH1 in-
teractions via CP motifs for heme-mediated Spic expression.
BACH1 has been shown to heterodimerize with MAFK to sup-
press Ho1 expression (Sun et al., 2002; Sun et al., 2004). In the
absence of BACH1, MAFK heterodimerizes with the transcrip-
tion activator NRF2 to activate Ho1 expression (Sun et al.,
2002; Sun et al., 2004). However, RPM frequency and Spic
expression were normal in Spicigf/igfp Nrf2/ mice, suggesting
that while Spic and Ho1 are both repressed by BACH1, they
rely on distinct activating factors (Figure 6H). Taken together,
these results demonstrate that heme-mediated induction of
Spic proceeds via proteasome-dependent degradation of the
transcriptional repressor BACH1 independently of NRF2.1230 Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc.Heme-Induced BACH1 Inhibition Promotes RPM and
BMM Development In Vivo
RPM and BMM were present at normal frequencies in Bach1/
mice (Figure 7A). To test for an in vivo role of Bach1 in the devel-
opment of RPM and BMM, we evaluated WT and Bach1/ BM
cells in an in vivo competitive setting. Bach1/ BM was signifi-
cantly more efficient than WT in generating RPM and BMM
(Figures 7B). This effect was specific to these lineages, since
Bach1/ BM was equal to WT in generating macrophages at
other locations and in generating other myeloid cells (Figures
7B and 7C). Since the competitive advantage of Bach1/ BM
in the generation of macrophages was evident only at sites of
active erythrophagocytosis, RPM development may involve
an additional step that is heme-dependent but Bach1-indepen-
dent. Thus, we compared gene expression in Bach1/ and
WT BMDM in the presence or absence of heme (Figure 7D). As
controls, we found that derepression of Spic, Ho1, and
Slc40a1 by heme was dependent on Bach1 (Figure 7D). Notably,
few genes were heme-induced but Bach1-independent; one
such gene was the RPM-associated marker Treml4 (Figures
7D and 7E). Therefore, BACH1 inhibition at sites of erythropha-
gocytosis controls RPM and BMM development through dere-
pression of Spic.
In summary, we identified the first environmental trigger
inducing development of a defined tissue-specific macrophage
subset. We showed that BACH1 was a transcriptional repressor
of Spic and that heme-induced proteasome-dependent degra-
dation of BACH1 protein in monocytes led to Spic expres-
sion and promoted RPM and BMM development (Figure 7F).
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Figure 6. Heme Degrades BACH1 to Derepress Spic Expression
(A) Mir155/ and WT splenocytes were stained for the indicated markers as shown in the flow cytometry plots.
(B)Mir155/ andWTmice were treated IP with a single dose of 200 ml PBS or PDZ (2 mg in PBS). Splenocytes were harvested and stained for F4/80 and CD11b
48 hr or 6 weeks after treatment as shown in the flow cytometry plots.
(C)Mir155/ BMDMwere treated with heme (40 mM) or vehicle after 6 days in culture. RNA was extracted 24 hr later and RT-PCR performed with Spic and Hprt
specific primers as shown in the representative agarose gel.
(D) Spicigfp/igfp BMDM were treated with the indicated concentrations of heme or vehicle after 7 days in culture. Cells were harvested 24 hr. later and protein
extracted. Shown are the western blots with the indicated antibodies. An anti-BACH1 reactive band appears at significantly higher molecular weight (*) in the
presence of heme.
(E) Spicigfp/igfp BMDM were treated with heme (40 mM), heme with the proteasomal inhibitor MG132 (10 mM), or vehicle after 7 days in culture. Two days after
treatment the cells were stained for the indicated markers as shown in the flow cytometry plots.
(F) BACH1 protein contains six heme-binding cysteine-proline (CP) motifs (black circle), a ‘‘repressive’’ BTB domain (blue box) at the N terminus, and a basic DNA
binding region preceding a protein dimerization leucine zipper domain (bZIP, orange box). Mutant BACH1 was generated by mutating the four carboxy-terminal
CP motifs to AP (alanine-proline, red circles). Human 293T cell-based Phoenix-E cells were transfected with mouse WT or mutant Bach1 expression constructs.
Twenty-four hours later the cells were treated with heme (40 mM) with or without cycloheximide (CHX, 25 mg/ml) to block new protein synthesis as indicated. Total
protein was isolated 4 hr after treatments. Shown at the bottom are the western blots with the indicated antibodies.
(legend continued on next page)
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Figure 7. BACH1 Inhibition by Heme In-
duces RPM and BMM Development In Vivo
(A) WT and Bach1/ BM and splenocytes were
stained for the indicated markers as shown in the
flow cytometry plots.
(B and C) CD45.1+ C57BL/6 recipient mice were
lethally irradiated and injected with a mix of
CD45.2+ Bach1/ and CD45.2+/CD45.1+ WT BM
cells or with a mix of CD45.2+ WT and CD45.2+/
CD45.1+ WT BM cells. Seven to ten weeks after
transplant various organs were harvested. The
y axis represents the ratio of the percent CD45.2+
within donor-derived RPM (F4/80hiVCAM1hi),
BMM (F4/80hiVCAM1hi), peritoneal macrophages
(P-Mac, F4/80hi), kidney macrophages (K-Mac,
F4/80hi), dendritic cells (DC; CD11chiMHC-IIhi),
monocytes (Mono; CD11bhiLy6GLy6C+ in BM),
and neutrophils (Neu; CD11bhiLy6G+Ly6C in BM)
to the percent CD45.2+ within all donor-derived
CD45+ cells (bars: mean + SD). *p < 0.05 (n R 3,
Mann-Whitney U test). (D–E) Bach1/ BMDM
were treated with heme (40 mM) or vehicle after
6 days in culture.
(D) RNA was extracted 24 hr after treatment and
gene expression analysis performed using the
Affymetrix microarray platform. Shown is the fold
change in expression (y axis, log2 scale) of
selected heme-inducible genes.
(E) Cells were harvested 72 hr after treatment and
stained for the indicated markers as shown in the
flow cytometry plots.
(F) Heme-induced development of heme-degrad-
ing macrophages.Furthermore, we showed that this pathway was important in
maintaining RPM and BMM homeostasis during pathological
hemolysis.
DISCUSSION
RPM actively accrue heme via erythrophagocytosis, CD163 re-
ceptor-mediated uptake of circulating hemoglobin-haptoglobin
complexes, and CD91 receptor-mediated uptake of circulating
heme-hemopexin complexes (Hvidberg et al., 2005; Kristiansen
et al., 2001; Bratosin et al., 1998). Hemolysis and erythrocyte
damage lead to an acute buildup of heme in these cells, resulting
in heme-induced toxicity. Such pathological conditions therefore
have a ‘‘double impact’’ on the macrophage-based iron recy-
cling machinery: they acutely increase the quantity of heme
that must be degraded, while excess heme is toxic to the
same macrophages that degrade this substrate. Therefore, the
induction of Spic and the development of pre-RPM upon
increased environmental heme represent an important adaptive
response during pathologic hemolysis.(G) Spicigfp/igfp BMDM cultures were infected with retroviral vectors expressing on
gray bar), and mutant Bach1 and human Cd4 (mutant Bach1-RV, black bar). Four
after treatment, cells were harvested and stained for hCD4 and F4/80. Within ind
fected (hCD4) cells (right). Shown are the percentages (y axis) of EGFP-express
test).
(H) Splenocytes of the indicated genotypes were stained for the indicated marke
represent percentage of cells within the indicated gate. All data in this figure are r
group.
1232 Cell 156, 1223–1234, March 13, 2014 ª2014 Elsevier Inc.Recent studies have questioned the monocyte origin of mac-
rophages, instead suggesting that most tissue-resident macro-
phages are maintained by local proliferation (Schulz et al.,
2012a; Hashimoto et al., 2013). Although this may be true at
steady state, our findings support a critical role for monocytes
in maintaining RPM and BMM homeostasis during pathological
hemolysis. Similarly, monocytes may also be critical in maintain-
ing other tissue-resident macrophages in response to tissue-
specific insults. This suggests a dichotomy in the developmental
mechanisms that maintain tissue-resident macrophages at
steady state and under pathological conditions.
Both BMM and RPM have been implicated in heme degrada-
tion and iron recycling. Our finding that these tissue-resident
macrophage subsets share similar developmental pathways un-
derscores the importance of function, rather than location, in the
classification of tissue-resident macrophages. Notably, high
levels of HO1 expression, similar to those in RPM, have been
observed in macrophages located in human atherosclerotic pla-
ques (Boyle et al., 2009). Therefore, macrophages that are func-
tionally equivalent to Spic-dependent BMM and RPM mayly the human Cd4 (Empty-RV, empty bar), Bach1 and human Cd4 (Bach1-RV,
days after infection, cells were treated with heme (40 mM) or vehicle. Four days
ividual wells, infected cells (hCD4+) were analyzed separately (left) from unin-
ing cells within the F4/80+ gate (n = 3, bars: mean + SD). *p < 0.05 (unpaired t
rs as shown in the flow cytometry plots. Numbers in the flow cytometry plots
epresentative of two or more experiments with at least two mice or sample per
develop at other locations with increased environmental heme,
such as hematomas and atherosclerotic plaques. In this regard,
the expression of Spic in a small subset of liver macrophages is
intriguing. Livermacrophages are also known to engulf damaged
erythrocytes (Beaumont and Delaby, 2009). Therefore, Spic-
EGFP+ macrophages in the liver likely represent cells that
actively phagocytose erythrocytes.
BACH1 degradation by heme allows its binding partner MAFK
to heterodimerize with NRF2 to induce Ho1 expression (Sun
et al., 2002; Sun et al., 2004). However, Spic induction was not
dependent on NRF2. Furthermore, bioinformatic analysis of the
Spic locus did not reveal the presence of any classic MARE
sequences recognized by MAF. These findings suggest that
Spic regulation by BACH1 may be independent of MAFK, and
that BACH1 may suppress Spic as a homodimer or as a
heterodimer with an unknown partner.
In summary, our findings provide insights into iron homeosta-
sis by linking the development of iron-recycling macrophages in
the spleen and BM to a molecular substrate of their metabolic
function. This developmental pathway may be a paradigm
for the role of tissue-specific metabolites in the maintenance of
tissue-resident macrophages.
EXPERIMENTAL PROCEDURES
Generation of Spicigfp/+ Mice
Details on the generation of the targeting construct are provided in the Supple-
mental Information. The linearized vector was electroporated into EDJ22 em-
bryonic stem cells (129SvEv background) and targeted clones were identified
by Southern blot analysis with 50 and 30 probes. Blastocyst injections were per-
formed and male chimeras were bred to female 129SvEv mice.
Mice
129SvEv mice were purchased from Taconic. C57BL/6 mice and the congenic
strain B6.SJL-Ptprca Pepcb/BoyJ (B6.SJL) were purchased from the Jackson
Laboratory or NCI.Ho1/ andMir155/micewere purchased from the Jack-
son Laboratory. Nrf2/mice were kindly provided by Dr. Rajasekaran and Dr.
Wang at the University of Utah. Mice were bred and maintained in our specific
pathogen-free animal facility according to institutional guidelines.
Histology
Histology was performed on fixed and frozen 6-8 mm sections following estab-
lished protocols as described in the Supplemental Information.
Cell Preparation
BM and peritoneal cells were harvested with Iscove’s modified Dulbecco’s
medium (IMDM) with 10% FCS. Cells from the various organs were harvested
by digesting with enzymes in IMDM following established protocols as
described in the Supplemental Information.
Flow Cytometry and Cell Sorting
Flow cytometry was performed on a FACS Canto (BD Biosciences) and cell
sorting performed on a FACS Aria II (BD Biosciences) using established proto-
cols as described in the Supplemental Information. All flow cytometry data
were analyzed with FlowJo software (Tree Star).
Transplantation Assay
For BM chimeras, recipient mice were lethally irradiated with two staggered
doses of 550 rad several hours apart and transplanted by tail vein injection
with BM cells obtained from donor mice.
Monocyte Transfers
Monocytes were purified by MACS-based depletion and enrichment as
described in the figure legends. For transfer of Spic-EGFP+ and Spic-EGFPmonocytes, the MACS-purified monocytes were further subjected to cell sort-
ing. All recipient mice were treated with PDZ or PBS and some recipient mice
additionally received sublethal radiation with a single dose of 550 rad as
described in figure legends.
In Vitro Cultures
BM cells were collected as described above and cultured in IMDM + 10% FCS
supplemented with 20 ng/ml of GM-CSF (315-03, PeproTech), M-CSF (315-
02, PeproTech), or G-CSF (300-23, PeproTech) as indicated. Unless otherwise
specified, BMDM indicates the adherent BM-derivedmacrophages generated
in the presence of 20 ng/ml GM-CSF. Cells were plated at 23 105 /ml for GM-
CSF cultures and 0.5 3 106 /ml for M-CSF and G-CSF cultures.
Microarray Analysis
Gene expression analyses were carried out using Affymetrix platforms and
standard protocols as described in the Supplemental Information. All data
have been deposited at GEO (GSE46983, GSE46984, and GSE53796).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.01.069.
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